Skip to content

Study on the efficacy and EEG of accelerated deep transcranial magnetic stimulation in the treatment of elderly patients with depression

Study on the efficacy and EEG of accelerated deep transcranial magnetic stimulation in the treatment of elderly patients with depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098390
Enrollment
Unknown
Registered
2025-03-06
Start date
2025-03-06
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in old age

Interventions

intervention group:dTMS combined with SSRIs
Control group:Pseudostimulation combined with SSRIs treatment

Sponsors

Beijing Anding Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Patient signs written informed consent; 2) 60 years old = 17 5) Primary school education level or above, able to complete the scale assessment

Exclusion criteria

Exclusion criteria: 1) Those who are accompanied by suicidal ideation or suicidal behavior; 2) Those with a history of epilepsy or coronary heart disease or other serious unstable physical diseases; 3) Patients with a previous or current DSM-5 diagnosis of the following psychiatric disorders: organic mental disorder, Alzheimer's disease, secondary dementia due to other causes, schizophrenia, schizoaffective disorder, bipolar disorder, delusional disorder, undefined mental illness, patients with a history of substance abuse, including alcohol and active drug abuse in the past 12 months, except nicotine; 4) Participation in another interventional clinical study within the past 1 month; 5) Those who are unable to complete the experiment with severe aphasia, visual and hearing impairment, etc.; 6) Those who have undergone electroconvulsive therapy and transcranial magnetic stimulation therapy in the 3 months before screening 7) Use of non-SSRIs antidepressants in the past 2 weeks

Design outcomes

Primary

MeasureTime frame
Between-group difference in change from baseline in the total score of the Participant Scale (HAMD-17) between the two groups at the end of 4 weeks;The power of the EEG a wave and the asymmetry of the a wave, taken as d (0. 5 ~ 4 Hz), ? (4 ~ 8 Hz), a (8 ~ 13 Hz), ß (13 ~ 30 Hz) energy values and ?/ß power ratios;

Secondary

MeasureTime frame
score of Pittsburghsleep Quality Index, PSQI;score of the Geriatric Depression Scale ,GDS; score of Hamilton Anxiety Rating Scale, HAMA; score of Montgomery-Asberg Depression Rating Scale, MADRS;score of Montreal Cognitive Assessment scale, MoCA;score of Activity of Daily Living Scale;

Countries

China

Contacts

Public ContactQinge Zhang

Beijing Anding Hospital Affiliated to Capital Medical University

zqe81@126.com+86 138 1159 1959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026